Company Filing History:
Years Active: 2019-2024
Title: The Innovations of Philippe Marliére
Introduction
Philippe Marliére is a notable inventor based in Luxembourg, LU. He has made significant contributions to the field of biochemistry, particularly in the development of enzyme variants that enhance the production of valuable chemical compounds. His work has implications for both industrial applications and scientific research.
Latest Patents
Marliére holds a patent for 3-hydroxyisovalerate (HIV) synthase variants. This patent describes variants that exhibit improved activity in converting acetone and a compound that provides an activated acetyl group into 3-hydroxyisovalerate. Additionally, the patent outlines methods for producing 3-hydroxyisovalerate and for generating isobutene from acetone using these innovative HIV synthase variants.
Career Highlights
Throughout his career, Philippe Marliére has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Global Bioenergies, where he contributed to advancements in biofuels and renewable resources. He has also served as a scientist at Fortune, S.a., further showcasing his expertise in the field.
Collaborations
Marliére has collaborated with esteemed colleagues, including Marc Delcourt and Sabine Mazaleyrat. These partnerships have fostered innovation and have been instrumental in advancing research in biochemistry and related fields.
Conclusion
Philippe Marliére's contributions to the field of biochemistry, particularly through his patent on HIV synthase variants, highlight his role as an influential inventor. His work continues to impact the industry and pave the way for future innovations.